Headlands Technologies LLC Blueprint Medicines Corp Transaction History
Headlands Technologies LLC
- $401 Million
- Q1 2024
A detailed history of Headlands Technologies LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Headlands Technologies LLC holds 667 shares of BPMC stock, worth $77,338. This represents 0.02% of its overall portfolio holdings.
Number of Shares
667
Previous 325
105.23%
Holding current value
$77,338
Previous $29,000
117.24%
% of portfolio
0.02%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding BPMC
# of Institutions
313Shares Held
60.6MCall Options Held
634KPut Options Held
691K-
Black Rock Inc. New York, NY6.45MShares$748 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.31MShares$732 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.25MShares$725 Million0.07% of portfolio
-
Wellington Management Group LLP Boston, MA4.18MShares$484 Million0.07% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.5MShares$290 Million6.2% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.92B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...